Cost-utility and budget impact analyses of gefitinib in...

Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspective

Sumitra THONGPRASERT, Sirana TINMANEE, Unchalee PERMSUWAN
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Year:
2012
Language:
english
Pages:
9
DOI:
10.1111/j.1743-7563.2012.01528.x
File:
PDF, 423 KB
english, 2012
Conversion to is in progress
Conversion to is failed